Speech-Language Pathologists in San Lorenzo, PR Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Mrs. Ivette Margarita Moctezuma, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Anexo Jardines De Cerro Gordo 139, San Lorenzo, PR 00754 Phone: 787-736-8255

Laura Frontera Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 274 Savannah Real, San Lorenzo, PR 00754 Phone: 787-745-2410

Maria Carmen Aponte, MASTER SPEECH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 43 Paseo Castilla, Urb. Savannah Real, San Lorenzo, PR 00754 Phone: 787-715-0119

Leslie Ann Vazquez-davila Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: F10a Calle 4, Urbanizacion Jardines De San Lorenzo, San Lorenzo, PR 00754 Phone: 787-380-8614

Zuania M Serrano, MS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 71 Calle A, Urb. Masso, San Lorenzo, PR 00754 Phone: 787-371-2048

Gloriana Cruz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Plaza Buxo, Edificio 2, Local 3, San Lorenzo, PR 00754 Phone: 787-210-2930

Ms. Vilma Enid Reyes Zayas, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 60 Paseo Castilla, Savannah Real, San Lorenzo, PR 00754 Phone: 787-502-9074

Praxis Cps Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3b Calle Abanico, Urb Aponte, San Lorenzo, PR 00754 Phone: 787-202-4611

News Archive

Racial differences in life expectancy vary substantially across U.S. states

Racial differences in life expectancy have declined nationally but still vary substantially across U.S. states, according to a new study by McGill University researchers.

RANK inhibitor-chemotherapy combination may have important therapeutic effects against breast cancer

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that overactivation of the RANK signalling pathway promotes the initiation, progression and metastasis of tumours in human breast epithelial cells by dedifferentiation of breast cells to stem cells. The results of this study have been advanced in the electronic edition of the journal Cancer Research.

TAU's Yosef Shiloh receives Olav Thon Foundation's first international research award

Norway's largest charitable organization, the Olav Thon Foundation, which invests heavily in medical research, awarded its first international research award in the medical and natural sciences to Tel Aviv University's Prof. Yosef Shiloh and Prof. Judith Campisi of the Buck Institute for Research on Aging, California.

AHF urges Gilead to set initial price on latest HIV/AIDS drug combination

AIDS Healthcare Foundation (AHF) announced that California State Treasurer Bill Lockyer has sent a letter to California-based drug company, Gilead Sciences, Inc. urging the company to set an initial price on its latest HIV/AIDS drug combination—which is known as the 'Quad'—that is "…sensitive to ongoing state budget difficulties," and which will also "…provide the means to keep people with HIV/AIDS alive and as healthy as possible."

Read more Medical News

› Verified 4 days ago